- Advanced search
- Immuno Portal
- Malaria Portal
pegfilgrastim is an approved drug (FDA and EMA (2002))
Compound class: Peptide or derivative
Comment: This is a PEGylated version of recombinant human G-CSF. Pegylation increases circulating half-life. In addition to pegfilgrastim, lipegfilgrastim (Lonquex®) is a glyco-PEGylated long-acting G-CSF, that is an alternative to pegfilgrastim that is clinically approved .